Reporter July 10 2015

July 15, 2015

Drug signaling networks

Vanderbilt investigators have developed a new algorithm to understand the networks of signaling molecules that control drug action.

By Leigh MacMillan
July 13, 2015

Hhex on cancer

A new mouse model demonstrates that the Hhex gene – which is linked to blood cancers – is critical for normal blood cell production.

By Henry H. Ong
July 10, 2015

Delivering cells for heart repair

A polymer hydrogel material developed by Vanderbilt scientists improved the delivery of stem cells for heart repair.

By Leigh MacMillan
July 9, 2015

Signals of schizophrenia

Vanderbilt researchers have discovered a possible molecular mechanism of schizophrenia that could lead to new treatments for the disorder.

By VUMC News and Communications
July 9, 2015

VUMC lands major pharmacogenomics grant

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given.

By Bill Snyder
July 9, 2015

Gates grant bolsters study of Tdap boosters in pregnant women

Kathryn Edwards, M.D., director of the Vanderbilt Vaccine Research Program, has received a $307,000 grant from the Bill & Melinda Gates Foundation to study the immune responses of pregnant women who receive the Tdap (reduced-dose acellular pertussis vaccines combined with tetanus and diphtheria toxoids) vaccine.

By Matt Batcheldor
July 9, 2015

Harvey named senior VP of Revenue Cycle Services

Gayla Harvey has been named senior vice president of Revenue Cycle Services and Payer Strategy for Vanderbilt University Medical Center.
By VUMC News and Communications
July 9, 2015

Move to new ICD-10 medical coding system progressing

A team of Vanderbilt University Medical Center project managers has been working in recent months to train staff and transition clinics to a new medical coding and reporting system set to go into effect later this year.
By VUMC News and Communications
July 9, 2015

Arteaga, AACR push for cancer research funding

Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), recently joined other cancer research leaders in a meeting with members of Congress to discuss precision medicine in cancer and the need for continued federal support for cancer research.
By VUMC News and Communications
July 9, 2015

Guengerich named interim editor of noted journal JBC

Vanderbilt University’s F. Peter (Fred) Guengerich, Ph.D., has been named interim editor-in-chief of the Journal of Biological Chemistry (JBC).
By Bill Snyder
July 9, 2015

Update from Kevin Johnson about Clinical Systems 2.0

CS 2.0 started with McKesson announcing that the Horizon suite of software used at VUMC would no longer be supported in 2018. We are using this announcement as a motivator to evaluate all our systems and plan for what our patients, our staff and our faculty need in the future.
By VUMC News and Communications
July 9, 2015

Improving patients’ quality of life drives Lind’s clinical care

As a gastroenterologist, Christopher Lind, M.D., says he is often the “butt” of jokes, but few people truly appreciate the role the gut plays in their happiness.
By VUMC News and Communications
July 9, 2015

Study could lead to vaccine for mosquito-borne dengue virus

Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus.
By Bill Snyder